Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Farmers Insurance
Covington
Teva
Boehringer Ingelheim
Chinese Patent Office
McKinsey
Baxter
Colorcon

Generated: June 24, 2018

DrugPatentWatch Database Preview

AMELUZ Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Ameluz patents expire, and what generic alternatives are available?

Ameluz is a drug marketed by Biofrontera and is included in one NDA. There is one patent protecting this drug.

This drug has thirteen patent family members in eleven countries.

The generic ingredient in AMELUZ is aminolevulinic acid hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aminolevulinic acid hydrochloride profile page.
Summary for AMELUZ
Drug patent expirations by year for AMELUZ
Pharmacology for AMELUZ
Ingredient-typePorphyrinogens
Drug ClassPorphyrin Precursor
Medical Subject Heading (MeSH) Categories for AMELUZ
Synonyms for AMELUZ
.delta.-Aminolevulinic acid hydrochloride
0C1E43DB-1221-4963-BFA4-18D3170000A4
4-carboxy-2-oxobutan-1-aminium chloride
451A092
5 ALA HCL
5-amino levulinic acid hydrochloride
5-Amino-3-oxopentanoic acid (hydrochloride)
5-amino-4-keto-valeric acid
5-Amino-4-ketovaleric acid hydrochloride
5-AMINO-4-OXOPENTANOIC ACID HCL
5-Amino-4-oxopentanoic acid hydrochloride
5-amino-4-oxopentanoic acid hydrochloride;5-Amino-4-oxopentanoic acid
5-amino-4-oxopentanoic acid, chloride
5-Amino-4-oxovaleric acid hydrochloride
5-amino-levulinic acid hydrochloride
5-Aminolaevulinic acid hydrochloride
5-Aminolevulinate hydrochloride
5-Aminolevulinic acid (hydrochloride)
5-Aminolevulinic acid HCl
5-Aminolevulinic acid hydrochloride
5-aminolevulinic acid hydrochloride salt
5-Aminolevulinic acid hydrochloride, >=97.0% (AT)
5-Aminolevulinic acid hydrochloride, >=98%
5-Aminolevulinic acid hydrochloride, BioReagent, suitable for cell culture, powder, >=98%
5-Aminolevulinic acid hydrochloride, GMP
5-Aminolevulinic acid hydrochloride, particle size < 0.25 mm
5-Aminolevulinic Acid, Hydrochloride Salt
5-aminolevulinic acid.HCl
5451-09-2
A-6100
A-6102
A-6103
A0325
AB1005459
AC-4252
AC1L3WYV
AC1Q5HEA
ACT05562
AK-30504
AKOS015904495
ALA HCl
ALA-PDT
AlaCare
AM20100341
Ameluz (TN)
Aminolevulinic Acid HCl
Aminolevulinic acid hydrochloride
Aminolevulinic acid hydrochloride (JAN/USAN)
Aminolevulinic acid hydrochloride [USAN]
Aminolevulinic acid hydrochloride, United States Pharmacopeia (USP) Reference Standard
ANW-43114
AT-6127
AX8102341
BC210778
BCP9000174
BR-30504
C-04944
C5H9NO3.HCl
CA-291
CAS-5451-09-2
CC-21174
CCG-39079
CHEBI:132969
CHEMBL1200582
CS-2575
CTK1G9933
D02908
D0O4GY
DB-005367
delta-Aminolevulinic acid hydrochloride
DSSTox_CID_25914
DSSTox_GSID_45914
DSSTox_RID_81222
DTXSID5045914
EINECS 226-679-5
FT-0082845
Gleolan
Gliolan
GM8475
GS-3020
HMS1922F13
HY-N0305
I14-1649
KB-196689
KB-244625
KS-000001DZ
KSC269S3H
Levulan
Levulan (TN)
Levulan Kerastick
Levulinic acid, 5-amino-, hydrochloride
Levulinic acid, 5-amino-, hydrochloride (8CI)
LS-87948
M-2865
MCULE-8125179397
MFCD00012869
MolPort-001-757-321
NCGC00095111-01
NCGC00095111-02
NCGC00095111-03
NCGC00178086-03
NSC 18509
NSC-18509
NSC-758687
NSC18509
NSC758687
OR002139
OR1490
PD-P-506-A
Pentanoic acid, 5-amino-4-oxo-, hydrochloride
Pentanoic acid, hydrochloride
Pentanoicacid, 5-amino-4-oxo-, hydrochloride (1:1)
Pharmakon1600-01504184
RL04038
RP23037
RTR-019277
S2553
SBB003880
SC-18502
SC-52394
SCHEMBL192308
SPECTRUM1504184
ST2411714
ST50824911
Tox21_111426
Tox21_111426_1
TPC-I025
TR-019277
UNII-V35KBM8JGR
V35KBM8JGR
ZLHFONARZHCSET-UHFFFAOYSA-N
ZX-AT009947

US Patents and Regulatory Information for AMELUZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biofrontera AMELUZ aminolevulinic acid hydrochloride GEL;TOPICAL 208081-001 May 10, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Biofrontera AMELUZ aminolevulinic acid hydrochloride GEL;TOPICAL 208081-001 May 10, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Argus Health
Healthtrust
Cipla
Julphar
US Army
Accenture
Moodys
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.